ArticleInternational journal of clinical and experimental medicine2015

Gemcitabine plus S-1 versus cetuximab as a third-line therapy in metastatic colorectal cancer: an observational trial.

Ming Bai et al.PubMed ↗Full text ↗

No numbers read from the abstract.